Korea’s Biotech Revolution Meets a Regulatory Wall: Why 2026 Is the Golden Time for Reform - KoreaTechDesk | Korean Startup and Technology News Korea’s biotech surge faces its toughest test yet—regulatory lag. 2026 may decide if K-Bio becomes a true global powerhouse or stalls at the edge of reform.

🧬 Korea’s biotech exports soar past ₩20T, but old rules risk slowing innovation ⚖️

Experts call 2026 the golden time for reform — a make-or-break year for K-Bio’s global rise 🌍

🔗 koreatechdesk.com/korea-biotec...
#KoreaTechDesk #KBio #Biotech #Innovation #KoreanStartups #Reform